drugset / Trial / NCT00613431

Effects of CS-8080 in Healthy Volunteers

NCT00613431 ↗

Phase 1 Completed 72 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purposes of this study are to assess the safety and measure the pharmacokinetics of CS-8080 in healthy volunteers.

Timeline

Start
2008-01
Primary completion
2008-08
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CS8080 Unknown 1 mg —
Subject CS8080 Unknown 3 mg —
Subject CS8080 Unknown 10 mg —
Subject CS8080 Unknown 20 mg —
Subject CS8080 Unknown 50 mg —
Subject CS8080 Unknown 100 mg —

Indications

No indication recorded.